| J0178 | Injection, aflibercept, 1 mg | 2 | 10 | 440 | $630 | $1.2M |
| Q5124 | Injection, ranibizumab-nuna, biosimilar, (byooviz), 0.1 mg | 1 | 10 | 3,150 | $210 | $654.5K |
| J2777 | Injection, faricimab‑svoa, 0.1 mg | 1 | 10 | 320 | $790 | $605.7K |
| J2778 | Injection, ranibizumab, 0.1 mg | 1 | 10 | 2,360 | $260 | $536.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 633 | 3,670 | 680 | $90 | $310K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 713 | 3,280 | 610 | $80 | $296.1K |
| 92060 | The basic eye sensorimotor exam checks the alignment of the eyes and their ability to move together in eight fields of gaze ( up, down, right, left, up–left, up–right, down–left, down–right) and… | 11 | 20 | 760 | $50 | $127.6K |
| 67028 | The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye. | 2 | 30 | 460 | $40 | $103K |
| 99204 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the provider… | 187 | 930 | 110 | $100 | $90.1K |
| 92134 | The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes. | 2 | 80 | 220 | $30 | $82K |